rotenone has been researched along with Cerebral Infarction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de los Ríos, C; Estrada, M; González-Lafuente, L; Lajarín-Cuesta, R; López, MG; Lorrio, S; Marco-Contelles, J; Martínez-Sanz, FJ; Rodríguez-Franco, MI; Romero, A; Samadi, A; Villarroya, M | 1 |
1 other study(ies) available for rotenone and Cerebral Infarction
Article | Year |
---|---|
PP2A ligand ITH12246 protects against memory impairment and focal cerebral ischemia in mice.
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Calcium Signaling; Cell Line; Cerebral Infarction; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Drug Evaluation, Preclinical; Hippocampus; Memory Disorders; Mice; Molecular Structure; Molecular Targeted Therapy; Naphthyridines; Nerve Tissue Proteins; Neuroprotective Agents; Oligomycins; Oxidative Stress; Phosphorylation; Protein Phosphatase 2; Protein Processing, Post-Translational; Rats; Rotenone; Scopolamine; tau Proteins | 2013 |